Ferring Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
1:17-cv-00435
Overview
Parties
Defendant
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Ferring Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8450338
Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
|
Filed: 2011-09-27
Issued: 2013-05-28
|
Active (1.9 yrs remaining)
Expires: 2028-10-19
|
|
|
US8481083
Granular compositions of magnesium oxide and citric acid and uses thereof
|
Filed: 2008-10-10
Issued: 2013-07-09
|
Active (1.9 yrs remaining)
Expires: 2028-10-10
|
|
|
US9669110
Method for timing a colonoscopy
|
Filed: 2012-07-16
Issued: 2017-06-06
|
Active (6.0 yrs remaining)
+133d PTA
Expires: 2032-11-26
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
23
Dispositive
0
Granted
2
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings